Consortia
Ingredient consortia bring together interested parties active in the consumer health sector, under a single management and budget, for the purpose of preparing and/or generating information to support the continued use of an ingredient in self-care products, notably in the context of risk assessment and market access procedures towards the European Commission or other European regulatory/scientific bodies.
Ingredient consortia managed by AESGP are open to all market operators (AESGP members as well as non-members) and are self-funded.
Information generated or acquired by a consortium is the property of the consortium members and is not, in principle, accessible to non-members of the consortium.
Membership is open throughout the life of the consortium, provided that a fair contribution to the accumulated costs is made. At any time, an interested market operator may apply to join a consortium as a late joiner.
Consortia at AESGP
AESGP has initiated discussions in the pre-consortium phase for the following ingredients:
- Acetylsalicylic Acid
- Dextromethorphan
- Ibuprofen
- Paracetamol
- Pseudoephedrine
If you are interested, as a non-member, in joining any of the above pre-consortium discussions prior to the signing of the respective consortium agreement, please get in touch with us at consortia@aesgp.eu for further information.